The Leadership Team at KromaTiD drives the strategic direction and operational efficiency of the company, ensuring alignment with its mission to enhance the understanding of genetic abnormalities. Comprising key executives including the Chief Financial Officer, Chief Technology Officer, and Chief Operating Officer, this team collaborates to oversee financial planning, technological innovation, and effective operations, fostering a culture of excellence and research advancement in molecular cytogenetics.
View all